Hormone replacement therapy and cobalamin status in elderly women

Ralph Carmel, Jeanne M. Howard, Ralph Green, Donald W. Jacobsen, Colleen Azen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Serum cobalamin concentrations are frequently low in the elderly but the cause is often not apparent. Because oral contraceptives have been associated with low cobalamin concentrations in young women, we compared hormone use with cobalamin status in elderly women to determine whether it could account for their unexplained low cobalamin concentrations. Thirty-eight of the 111 women had abnormal cobalamin status (defined by low cobalamin, elevated methylmalonic acid, and/or elevated homocysteine concentrations) and 73 had normal status. There was no difference in hormone use between the two groups: 7 (18.4%) of the 38 cobalamin-deficient subjects used estrogens compared with 20 (27.4%) of the 73 control subjects. No differences in hormone use were apparent either when analysis was confined to abnormal serum cobalamin concentrations alone. Similarly, the 27 women taking hormones and the 84 women not taking hormones did not have significantly different serum cobalamin or serum total homocysteine concentrations. Indeed, hormone users had slightly, though not significantly, higher cobalamin concentrations and lower homocysteine concentrations than nonusers; furthermore, hormone users also had significantly lower serum methylmalonic acid concentrations. Thus, neither cobalamin concentrations nor cobalamin metabolic status were significantly worse in elderly women taking estrogen than in those not taking it (and, if anything, may have been slightly better). Hormone use does not appear to be a significant contributor to the low cobalamin concentrations or the mild metabolic evidence of cobalamin deficiency so often seen in the elderly.

Original languageEnglish (US)
Pages (from-to)856-859
Number of pages4
JournalAmerican Journal of Clinical Nutrition
Volume64
Issue number6
StatePublished - Dec 1996

Fingerprint

hormone replacement therapy
Hormone Replacement Therapy
vitamin B12
Vitamin B 12
hormones
Hormones
homocysteine
Homocysteine
Methylmalonic Acid
methylmalonic acid
Serum
estrogens
Estrogens
oral contraceptives
Oral Contraceptives

Keywords

  • aging
  • Cobalamin
  • estrogen
  • homocysteine
  • methylmalonic acid

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Carmel, R., Howard, J. M., Green, R., Jacobsen, D. W., & Azen, C. (1996). Hormone replacement therapy and cobalamin status in elderly women. American Journal of Clinical Nutrition, 64(6), 856-859.

Hormone replacement therapy and cobalamin status in elderly women. / Carmel, Ralph; Howard, Jeanne M.; Green, Ralph; Jacobsen, Donald W.; Azen, Colleen.

In: American Journal of Clinical Nutrition, Vol. 64, No. 6, 12.1996, p. 856-859.

Research output: Contribution to journalArticle

Carmel, R, Howard, JM, Green, R, Jacobsen, DW & Azen, C 1996, 'Hormone replacement therapy and cobalamin status in elderly women', American Journal of Clinical Nutrition, vol. 64, no. 6, pp. 856-859.
Carmel, Ralph ; Howard, Jeanne M. ; Green, Ralph ; Jacobsen, Donald W. ; Azen, Colleen. / Hormone replacement therapy and cobalamin status in elderly women. In: American Journal of Clinical Nutrition. 1996 ; Vol. 64, No. 6. pp. 856-859.
@article{f62dd9c5103e4421886acd7ef2a8cbe3,
title = "Hormone replacement therapy and cobalamin status in elderly women",
abstract = "Serum cobalamin concentrations are frequently low in the elderly but the cause is often not apparent. Because oral contraceptives have been associated with low cobalamin concentrations in young women, we compared hormone use with cobalamin status in elderly women to determine whether it could account for their unexplained low cobalamin concentrations. Thirty-eight of the 111 women had abnormal cobalamin status (defined by low cobalamin, elevated methylmalonic acid, and/or elevated homocysteine concentrations) and 73 had normal status. There was no difference in hormone use between the two groups: 7 (18.4{\%}) of the 38 cobalamin-deficient subjects used estrogens compared with 20 (27.4{\%}) of the 73 control subjects. No differences in hormone use were apparent either when analysis was confined to abnormal serum cobalamin concentrations alone. Similarly, the 27 women taking hormones and the 84 women not taking hormones did not have significantly different serum cobalamin or serum total homocysteine concentrations. Indeed, hormone users had slightly, though not significantly, higher cobalamin concentrations and lower homocysteine concentrations than nonusers; furthermore, hormone users also had significantly lower serum methylmalonic acid concentrations. Thus, neither cobalamin concentrations nor cobalamin metabolic status were significantly worse in elderly women taking estrogen than in those not taking it (and, if anything, may have been slightly better). Hormone use does not appear to be a significant contributor to the low cobalamin concentrations or the mild metabolic evidence of cobalamin deficiency so often seen in the elderly.",
keywords = "aging, Cobalamin, estrogen, homocysteine, methylmalonic acid",
author = "Ralph Carmel and Howard, {Jeanne M.} and Ralph Green and Jacobsen, {Donald W.} and Colleen Azen",
year = "1996",
month = "12",
language = "English (US)",
volume = "64",
pages = "856--859",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Hormone replacement therapy and cobalamin status in elderly women

AU - Carmel, Ralph

AU - Howard, Jeanne M.

AU - Green, Ralph

AU - Jacobsen, Donald W.

AU - Azen, Colleen

PY - 1996/12

Y1 - 1996/12

N2 - Serum cobalamin concentrations are frequently low in the elderly but the cause is often not apparent. Because oral contraceptives have been associated with low cobalamin concentrations in young women, we compared hormone use with cobalamin status in elderly women to determine whether it could account for their unexplained low cobalamin concentrations. Thirty-eight of the 111 women had abnormal cobalamin status (defined by low cobalamin, elevated methylmalonic acid, and/or elevated homocysteine concentrations) and 73 had normal status. There was no difference in hormone use between the two groups: 7 (18.4%) of the 38 cobalamin-deficient subjects used estrogens compared with 20 (27.4%) of the 73 control subjects. No differences in hormone use were apparent either when analysis was confined to abnormal serum cobalamin concentrations alone. Similarly, the 27 women taking hormones and the 84 women not taking hormones did not have significantly different serum cobalamin or serum total homocysteine concentrations. Indeed, hormone users had slightly, though not significantly, higher cobalamin concentrations and lower homocysteine concentrations than nonusers; furthermore, hormone users also had significantly lower serum methylmalonic acid concentrations. Thus, neither cobalamin concentrations nor cobalamin metabolic status were significantly worse in elderly women taking estrogen than in those not taking it (and, if anything, may have been slightly better). Hormone use does not appear to be a significant contributor to the low cobalamin concentrations or the mild metabolic evidence of cobalamin deficiency so often seen in the elderly.

AB - Serum cobalamin concentrations are frequently low in the elderly but the cause is often not apparent. Because oral contraceptives have been associated with low cobalamin concentrations in young women, we compared hormone use with cobalamin status in elderly women to determine whether it could account for their unexplained low cobalamin concentrations. Thirty-eight of the 111 women had abnormal cobalamin status (defined by low cobalamin, elevated methylmalonic acid, and/or elevated homocysteine concentrations) and 73 had normal status. There was no difference in hormone use between the two groups: 7 (18.4%) of the 38 cobalamin-deficient subjects used estrogens compared with 20 (27.4%) of the 73 control subjects. No differences in hormone use were apparent either when analysis was confined to abnormal serum cobalamin concentrations alone. Similarly, the 27 women taking hormones and the 84 women not taking hormones did not have significantly different serum cobalamin or serum total homocysteine concentrations. Indeed, hormone users had slightly, though not significantly, higher cobalamin concentrations and lower homocysteine concentrations than nonusers; furthermore, hormone users also had significantly lower serum methylmalonic acid concentrations. Thus, neither cobalamin concentrations nor cobalamin metabolic status were significantly worse in elderly women taking estrogen than in those not taking it (and, if anything, may have been slightly better). Hormone use does not appear to be a significant contributor to the low cobalamin concentrations or the mild metabolic evidence of cobalamin deficiency so often seen in the elderly.

KW - aging

KW - Cobalamin

KW - estrogen

KW - homocysteine

KW - methylmalonic acid

UR - http://www.scopus.com/inward/record.url?scp=0029843374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029843374&partnerID=8YFLogxK

M3 - Article

C2 - 8942408

AN - SCOPUS:0029843374

VL - 64

SP - 856

EP - 859

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6

ER -